TY - JOUR
T1 - Genetic Engineering of Therapeutic Cells with the Sodium Iodide Symporter (NIS) to Enable Noninvasive In Vivo Therapy Tracking
AU - Grimsdell, Ben
AU - Saleem, Adeel
AU - Volpe, Alessia
AU - Fruhwirth, Gilbert O
N1 - Funding Information:
BG and AS were supported by PhD studentships from the MRC-funded Doctoral Training Programme in Health Sciences at King’s College London. AV is supported by The Center for ExperimentalImmuno-OncologyFellowshipAward (FP00001443), the Tow Foundation Fellowship Award (FP000004141) and the Fiona and Stanley Druckenmiller Center for Lung Cancer Research Fellowship Award (FP00005072) at Memorial Sloan Kettering Cancer Center. Further support was received by an NIH/NCI Cancer Center Support Grant to MSKCC (P30 CA008748). This work was further supported by a Cancer Research UK grant [C48390/A21153] to GOF. This work was further supported by the Cancer Research UK Centre of London, the National Institute for Health Research (NIHR) Bio-medical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, the MRC Centre for Transplantation at King’s College London [MR/J006742/1], and the Wellcome/EPSRC Centre for Medical Engineering at King’s College London [WT 203148/Z/16/Z]. The views expressed are those of the authors and not necessarily those of the NIHR, the National Health Service, or the Department of Health.
Publisher Copyright:
© The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024
Y1 - 2024
N2 - Noninvasive long-term imaging of therapeutic cells in preclinical models can be achieved through introducing a reporter gene into the cells of interest. Despite important recent developments such as gene editing, cell engineering based on lentiviruses remains a mainstream tool for gene transfer applicable to a variety of different cell types.In this chapter, we describe how to use lentivirus-based genetic engineering to render different candidate cell therapies in vivo traceable by radionuclide imaging. We illustrate this reporter gene technology using the sodium iodide symporter (NIS), which is compatible with both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). For preclinical experimentation, we fused NIS with a suitable fluorescent protein such as monomeric GFP or RFP to streamline cell line generation and downstream analyses of ex vivo tissue samples. We present protocols for reporter gene engineering of human cardiac progenitor cells, regulatory T cells, and effector T cells as well as for the characterization experiments required to validate NIS-fluorescent protein reporter function in these candidate therapeutic cells.
AB - Noninvasive long-term imaging of therapeutic cells in preclinical models can be achieved through introducing a reporter gene into the cells of interest. Despite important recent developments such as gene editing, cell engineering based on lentiviruses remains a mainstream tool for gene transfer applicable to a variety of different cell types.In this chapter, we describe how to use lentivirus-based genetic engineering to render different candidate cell therapies in vivo traceable by radionuclide imaging. We illustrate this reporter gene technology using the sodium iodide symporter (NIS), which is compatible with both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). For preclinical experimentation, we fused NIS with a suitable fluorescent protein such as monomeric GFP or RFP to streamline cell line generation and downstream analyses of ex vivo tissue samples. We present protocols for reporter gene engineering of human cardiac progenitor cells, regulatory T cells, and effector T cells as well as for the characterization experiments required to validate NIS-fluorescent protein reporter function in these candidate therapeutic cells.
KW - Humans
KW - Positron-Emission Tomography/methods
KW - Symporters/genetics
KW - Tomography, Emission-Computed, Single-Photon
KW - Genetic Engineering
UR - http://www.scopus.com/inward/record.url?scp=85177750365&partnerID=8YFLogxK
U2 - 10.1007/978-1-0716-3499-8_18
DO - 10.1007/978-1-0716-3499-8_18
M3 - Article
C2 - 38006504
SN - 1064-3745
VL - 2729
SP - 303
EP - 330
JO - Methods in molecular biology (Clifton, N.J.)
JF - Methods in molecular biology (Clifton, N.J.)
ER -